CAH — Cardinal Health Inc. stock price and chart

CAH

Cardinal Health Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.09% · Russell 1000 0.08% · US Stock Market 0.08% · Russell 3000 0.08% · MSCI World 0.05% · MSCI ACWI 0.05%

$234.57-0.61%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

60.080.0100.0120.0140.0160.0180.0200.0220.0240.0020.0M$234.57

2026-09-11

Price$234.57

MA20$219.11

MA50$199.06

Vol7.9M

What would $1,000 invested in CAH be worth today? →

CAH returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $234.57
Change YTD: +14.96%
Next earnings: Oct 29, 2026
Market cap: 54.6B2016-09 24.9B2026-09 54.5B+119.3% over the window
Enterprise value: 60B
Shares outstanding: 232.6M2016-06 318.6M2026-06 232.6M-27.0% over the window
52W low: $145.87
52W high: $258.30
From 52W high: -9.19%
From 52W low: +60.81%
52W range: 79%
Beta: 0.50

Volume

Rel volume: 0.65×
30D volume: 1.7M
30D $ vol: 405M

Fundamentals

Sales (ttm): 254.2B2016-06 121.5B2026-06 254.2B+109.2% over the window
Sales/share: $1,093.182016-06 $381.512026-06 $1,093.18+186.5% over the window
EPS (ttm): $7.232016-06 $4.322026-06 $7.23+67.4% over the window
FCF (ttm): 4.5B2016-06 2.5B2026-06 4.5B+80.6% over the window
FCF/share: $19.462016-06 $7.872026-06 $19.46+147.3% over the window
Book value/share: -$12.402016-06 $20.572026-06 -$12.40-160.3% over the window
Net margin: 0.67%2016-06 1.2%2026-06 0.7%-42.6% over the window
ROA: 2.99%2016-06 4.2%2026-06 3.0%-28.5% over the window
Current ratio: 0.882016-06 1.112026-06 0.88-20.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +14.24%2025-06-30 → 2026-06-30222.6B → 254.2B (+14.2% total)+7.44%2023-06-30 → 2026-06-30205B → 254.2B (+24.0% total)+9.37%2021-06-30 → 2026-06-30162.5B → 254.2B (+56.5% total)+7.66%2016-06-30 → 2026-06-30121.5B → 254.2B (+109.2% total)
Net income: +9.81%2025-06-30 → 2026-06-301.6B → 1.7B (+9.8% total)+73.16%2023-06-30 → 2026-06-30330M → 1.7B (+419.4% total)+22.92%2021-06-30 → 2026-06-30611M → 1.7B (+180.5% total)+1.85%2016-06-30 → 2026-06-301.4B → 1.7B (+20.1% total)
FCF: +144.74%2025-06-30 → 2026-06-301.9B → 4.5B (+144.6% total)+24.17%2023-06-30 → 2026-06-302.4B → 4.5B (+91.5% total)+17.40%2021-06-30 → 2026-06-302B → 4.5B (+123.0% total)+6.09%2016-06-30 → 2026-06-302.5B → 4.5B (+80.6% total)
Shares: -2.61%2025-06-30 → 2026-06-30238.8M → 232.6M (-2.6% total)-2.47%2023-06-30 → 2026-06-30250.7M → 232.6M (-7.2% total)-4.35%2021-06-30 → 2026-06-30290.4M → 232.6M (-19.9% total)-3.10%2016-06-30 → 2026-06-30318.6M → 232.6M (-27.0% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +12.10%2025-06-30 → 2026-06-30$6.45 → $7.23 (+12.1% total)+79.00%2023-06-30 → 2026-06-30$1.26 → $7.23 (+473.8% total)+28.30%2021-06-30 → 2026-06-30$2.08 → $7.23 (+247.6% total)+5.29%2016-06-30 → 2026-06-30$4.32 → $7.23 (+67.4% total)
Sales/share: +17.30%2025-06-30 → 2026-06-30$932.09 → $1,093.18 (+17.3% total)+10.16%2023-06-30 → 2026-06-30$817.69 → $1,093.18 (+33.7% total)+14.34%2021-06-30 → 2026-06-30$559.38 → $1,093.18 (+95.4% total)+11.10%2016-06-30 → 2026-06-30$381.51 → $1,093.18 (+186.5% total)
FCF/share: +151.29%2025-06-30 → 2026-06-30$7.75 → $19.46 (+151.1% total)+27.32%2023-06-30 → 2026-06-30$9.43 → $19.46 (+106.4% total)+22.74%2021-06-30 → 2026-06-30$6.99 → $19.46 (+178.5% total)+9.48%2016-06-30 → 2026-06-30$7.87 → $19.46 (+147.3% total)
Dividend/share: +0.99%2025-06-30 → 2026-06-30$2.02 → $2.04 (+1.0% total)+1.00%2023-06-30 → 2026-06-30$1.98 → $2.04 (+3.0% total)+1.01%2021-06-30 → 2026-06-30$1.94 → $2.04 (+5.2% total)+2.79%2016-06-30 → 2026-06-30$1.55 → $2.04 (+31.6% total)
Price: +53.89%2025-09-11 → 2026-09-11$152.47 → $234.57 (+53.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+37.75%2023-09-11 → 2026-09-11$89.73 → $234.57 (+161.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+34.72%2021-09-10 → 2026-09-11$52.82 → $234.57 (+344.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+11.52%2016-09-09 → 2026-09-11$78.81 → $234.57 (+197.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +55.49%2025-09-11 → 2026-09-11$150.90 → $234.57 (+55.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+39.89%2023-09-11 → 2026-09-11$85.67 → $234.57 (+173.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+37.69%2021-09-10 → 2026-09-11$47.37 → $234.57 (+395.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+14.67%2016-09-09 → 2026-09-11$59.66 → $234.57 (+293.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 32.4×2016-09 18.372026-09 31.82+73.3% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 20.9×2016-09 10.482026-09 20.87+99.3% over the window
Fwd P/E: 17.1×
P/S (ttm)Market cap ÷ TTM revenue.: 0.2×2016-09 0.202026-09 0.21+8.3% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: -18.9×2016-09 3.822026-09 -18.92-595.4% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 12.1×2016-09 9.402026-09 12.05+28.2% over the window
EV/EBITDA (fy): 16.8×
EV/Sales (ttm): 0.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 8.29%2016-06 10.1%2026-06 8.1%-19.9% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.87%
Dividend/share (fwd): $2.04
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 232.6M ÷ 238.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 2.61%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (2.61%) + dividends paid over that year ($491M) ÷ market_cap_at(2025-06-30) ($40.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.83%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($1.4B) ÷ today's market cap ($54.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 2.49%2016-06 2.6%2026-06 2.4%-7.5% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $1.4B + TTM dividends $491M) ÷ today's market cap ($54.6B). Same caveat as the cash buyback yield.: 3.39%2016-06 4.7%2026-06 3.3%-29.5% over the window

Vs own 10Y history

P/E: 72nd
P/OI: 57th
P/S: 98th
P/B: 95th
P/FCF: 72nd

Bar = where today’s multiple sits in CAH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

-0.61%

-5.65%

+0.18%

+6.29%

YTD

+14.96%

+58.76%

+388.23%

Financial statements

Open full CAH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%

Cardinal Health Inc. (CAH) trades at $234.57 with a live price and an interactive chart covering 42+ years of daily price history, plus key valuation metrics. ChartRow also publishes CAH’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full CAH financial statements →

CAH — Cardinal Health Inc. price, chart and key statistics